Abstract:SUMMARY
Basal p53 levels are tightly suppressed under normal conditions. Disrupting this regulation results in elevated p53 levels to induce cell cycle arrest, apoptosis and tumor suppression. Here, we report the suppression of basal p53 levels by a nuclear, p53-regulated long noncoding RNA that we termed PURPL (p53 upregulated regulator of p53 levels). Targeted depletion of PURPL in colorectal cancer cells results in elevated basal p53 levels and induces growth defects in cell culture and in mouse xenografts.… Show more
“…In short, subcutaneous tumor xenografting was performed by injecting the right flank of nude mice with 1×10 7 cells that had been transfected with the indicated plasmids. After 4 weeks, the mice were sacrificed, and …”
Background/Aims: Long noncoding RNAs (lncRNAs) are critical regulators in various diseases including human cancer and could function as competing endogenous RNAs (ceRNAs) to regulate microRNAs (miRNAs). Methods: Quantitative real-time PCR (qRT-PCR) was used to analyze the expression of lnc-SNHG1 and miR-302/372/373/520 in pituitary tumor tissues and cell lines. Cell proliferation was investigated using MTT and cell count assays. The mechanisms by which lnc-SNHG1 affects pituitary tumor progression were investigated using Western blot assays, transwell migration assays, immunohistochemistry, immunofluorescence, luciferase reporter assays, tumor xenografts, and flow cytometry Results: We found that lnc-SNHG1 was overexpressed in invasive pituitary tumor tissues and cell lines. Ectopic expression of lnc-SNHG1 promoted cell proliferation, migration, and invasion, as well as the epithelial-mesenchymal transition (EMT), by affecting the cell cycle and cell apoptosis in vitro and tumor growth in vivo. Further study indicated that overexpression of lnc-SNHG1 markedly inhibited the expression of miR-302/372/373/520 (miRNA-pool) which is down-regulated in invasive pituitary tumor cells. Moreover, overexpression of lnc-SNHG1 significantly promoted the expression of TGFBR2 and RAB11A, the direct targets of miR-302/372/373/520. Finally, lnc-SNHG1 activates the TGFBR2/SMAD3 and RAB11A/Wnt/β-catenin pathways in pituitary tumor cells via sponging miR-302/372/373/520. Conclusions: Our data suggest that lnc-SNHG1 promotes the progression of pituitary tumors and is a potential therapeutic target for invasive pituitary tumor.
“…In short, subcutaneous tumor xenografting was performed by injecting the right flank of nude mice with 1×10 7 cells that had been transfected with the indicated plasmids. After 4 weeks, the mice were sacrificed, and …”
Background/Aims: Long noncoding RNAs (lncRNAs) are critical regulators in various diseases including human cancer and could function as competing endogenous RNAs (ceRNAs) to regulate microRNAs (miRNAs). Methods: Quantitative real-time PCR (qRT-PCR) was used to analyze the expression of lnc-SNHG1 and miR-302/372/373/520 in pituitary tumor tissues and cell lines. Cell proliferation was investigated using MTT and cell count assays. The mechanisms by which lnc-SNHG1 affects pituitary tumor progression were investigated using Western blot assays, transwell migration assays, immunohistochemistry, immunofluorescence, luciferase reporter assays, tumor xenografts, and flow cytometry Results: We found that lnc-SNHG1 was overexpressed in invasive pituitary tumor tissues and cell lines. Ectopic expression of lnc-SNHG1 promoted cell proliferation, migration, and invasion, as well as the epithelial-mesenchymal transition (EMT), by affecting the cell cycle and cell apoptosis in vitro and tumor growth in vivo. Further study indicated that overexpression of lnc-SNHG1 markedly inhibited the expression of miR-302/372/373/520 (miRNA-pool) which is down-regulated in invasive pituitary tumor cells. Moreover, overexpression of lnc-SNHG1 significantly promoted the expression of TGFBR2 and RAB11A, the direct targets of miR-302/372/373/520. Finally, lnc-SNHG1 activates the TGFBR2/SMAD3 and RAB11A/Wnt/β-catenin pathways in pituitary tumor cells via sponging miR-302/372/373/520. Conclusions: Our data suggest that lnc-SNHG1 promotes the progression of pituitary tumors and is a potential therapeutic target for invasive pituitary tumor.
“…As expected, we found that the expression of PRLH1 increased nearly up to eightfold in SK-HEP-1 cells, while remaining unchanged in HuH-7 cells after knockdown of p53 by siRNA ( Fig 1F). Notably, the knockout of p53 in HepG2 cells led to a remarkable decrease in the expression of the known p53-activated lncRNA PURPL [40] and a significant increase in the expression of other three lncRNAs (AC073236.3, RP11-81H3.2, and RP11-328N19.1) displayed in Fig 1C (Appendix Fig S1G), indicating that these three lncRNAs were also repressed directly or indirectly by wild-type p53. Notably, the knockout of p53 in HepG2 cells led to a remarkable decrease in the expression of the known p53-activated lncRNA PURPL [40] and a significant increase in the expression of other three lncRNAs (AC073236.3, RP11-81H3.2, and RP11-328N19.1) displayed in Fig 1C (Appendix Fig S1G), indicating that these three lncRNAs were also repressed directly or indirectly by wild-type p53.…”
Section: Prlh1 Is An Erv-9 Ltr Lncrna Regulated By P53mentioning
LTR retrotransposons are abundant repetitive elements in the human genome, but their functions remain poorly understood. Here, we report the function and regulatory mechanism of an ERV‐9 LTR retrotransposon‐derived lncRNA called p53‐regulated lncRNA for homologous recombination (HR) repair 1 (PRLH1) in human cells. PRLH1 is highly expressed in p53‐mutated hepatocellular carcinoma (HCC) samples and promotes cell proliferation in p53‐mutated HCC cells, and its transcription is promoted by NF‐Y and suppressed by p53. Mechanistically, PRLH1 specifically binds to an uncharacterized domain of RNF169 through two GCUUCA boxes in its 5′ terminal region to form a DNA repair complex that supplants 53BP1 at double‐strand break (DSB) sites and then promotes the initiation of HR repair. Notably, PRLH1 is essential for the stabilization of RNF169, acting as an RNA platform to recruit and assemble HR protein factors. This study characterizes PRLH1 as a novel HR‐promoting factor and provides new insights into the function and mechanism of LTR retrotransposon‐derived lncRNAs.
“…In a recent issue of Cell Reports, Li et al (22) identified and functionally characterized the p53-regulated lncRNA PURPL in colorectal cancer. PURPL was strongly induced by DNA damage and was predominant in nuclear.…”
mentioning
confidence: 99%
“…By RNA pulldown and mass spectrometry, Li et al (22) found strong interaction between PURPL and MYBBP1A, a protein that stabilizes p53. In light of the authors’ result that loss of PURPL increased p53 levels, they proposed that loss of PURPL freed up MYBBP1A, enabling it to bind and increase p53 stability.…”
mentioning
confidence: 99%
“…However, the studies by Yoon (10) and Li (22) discussed here bring into focus HuR as an RBP that can jointly suppress p53 function and reduce p53 levels. With escalating interest in developing therapies that raise p53 activity, particularly in combination with DNA-damaging treatments, new lines of effort could be devised based on these findings.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.